The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
The company says those insights can power advanced analytics and real-world evidence (RWE), helping researchers improve trial design, study feasibility, and recruitment strategies
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The new functionality complements Parse’s existing Evercode immune products
India in the Changing Landscape of Life-Sciences Research & Development
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
The company also reported significant progress toward its internally defined Sustainable Development Goals
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Subscribe To Our Newsletter & Stay Updated
